Notably, 2 out of the 10 adults showed weak circulating anti-S1 and anti-RBD IgG and nAb responses compared to the rest of the group despite their previous history of infection and receiving one or two doses of COVID-19 vaccine. The gene discussed is PSMD1; the disease is COVID-19.